JP2017523985A5 - - Google Patents

Download PDF

Info

Publication number
JP2017523985A5
JP2017523985A5 JP2017506294A JP2017506294A JP2017523985A5 JP 2017523985 A5 JP2017523985 A5 JP 2017523985A5 JP 2017506294 A JP2017506294 A JP 2017506294A JP 2017506294 A JP2017506294 A JP 2017506294A JP 2017523985 A5 JP2017523985 A5 JP 2017523985A5
Authority
JP
Japan
Prior art keywords
seq
acid sequence
amino acid
polypeptide
identity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017506294A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017523985A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/068012 external-priority patent/WO2016020413A1/en
Publication of JP2017523985A publication Critical patent/JP2017523985A/ja
Publication of JP2017523985A5 publication Critical patent/JP2017523985A5/ja
Pending legal-status Critical Current

Links

JP2017506294A 2014-08-05 2015-08-05 抗原用担体分子 Pending JP2017523985A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14179945.2 2014-08-05
EP14179945 2014-08-05
PCT/EP2015/068012 WO2016020413A1 (en) 2014-08-05 2015-08-05 Carrier molecule for antigens

Publications (2)

Publication Number Publication Date
JP2017523985A JP2017523985A (ja) 2017-08-24
JP2017523985A5 true JP2017523985A5 (enExample) 2018-07-19

Family

ID=51298571

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017506294A Pending JP2017523985A (ja) 2014-08-05 2015-08-05 抗原用担体分子

Country Status (16)

Country Link
US (1) US10245310B2 (enExample)
EP (1) EP3177324A1 (enExample)
JP (1) JP2017523985A (enExample)
KR (1) KR20170039709A (enExample)
CN (1) CN108064174A (enExample)
AR (1) AR101455A1 (enExample)
AU (1) AU2015299008B2 (enExample)
BE (1) BE1022792B1 (enExample)
BR (1) BR112017002183A2 (enExample)
CA (1) CA2957118A1 (enExample)
EA (1) EA201790239A1 (enExample)
IL (1) IL250238A0 (enExample)
MX (1) MX2017001638A (enExample)
SG (1) SG11201700673RA (enExample)
WO (1) WO2016020413A1 (enExample)
ZA (1) ZA201700824B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA95237C2 (uk) * 2005-06-27 2011-07-25 Ґлаксосмітклайн Байолоджікалз С.А. Імуногенна композиція
US20210108002A1 (en) 2016-12-06 2021-04-15 Glaxosmithkline Biologicals Sa Purification Process For Capsular Polysaccharide
IL317054A (en) 2016-12-30 2025-01-01 Vaxcyte Inc Polypeptide-antigen conjugates with unnatural amino acids
US11951165B2 (en) 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
KR20240149976A (ko) * 2017-04-04 2024-10-15 바린투스 바이오테라퓨틱스 노쓰 아메리카, 인크. 펩티드-기반 백신, 그의 제조 방법, 및 면역 반응을 유도하기 위한 그의 용도
WO2018229708A1 (en) 2017-06-16 2018-12-20 Glaxosmithkline Biologicals Sa Method of treatment
WO2019217665A1 (en) * 2018-05-09 2019-11-14 West Virginia University Iron-acquisition receptor peptide administration for vaccination against pseudomonas aeruginosa
EP3574915A1 (en) * 2018-05-29 2019-12-04 Neovacs Immunogenic product comprising il-4 and/or il-13 for treating disorders associated with aberrant il-4 and/or il 13 expression or activity
EP3817775B1 (en) * 2018-07-04 2024-09-04 Vaxcyte, Inc. Improvements in immunogenic conjugates
WO2020010000A1 (en) * 2018-07-04 2020-01-09 Sutrovax, Inc. Improved methods for the preparation of immunogenic conjugates
CN108840914B (zh) * 2018-08-13 2022-07-01 内蒙古民族大学 一种具有免疫原性的多肽、其抗体的制备方法以及用途
SG11202110803YA (en) * 2019-04-02 2021-10-28 Vaxcyte Inc Optimized cell-free synthesis of invasion plasmid antigen b and related compositions and methods of use
BR112022008761A2 (pt) 2019-11-22 2022-07-26 Glaxosmithkline Biologicals Sa Dosagem e administração de uma vacina de glicoconjugado de sacarídeo
WO2021250625A2 (en) 2020-06-12 2021-12-16 Glaxosmithkline Biologicals Sa Gbs ferritin nanoparticles
WO2021250626A2 (en) * 2020-06-12 2021-12-16 Glaxosmithkline Biologicals Sa Dock tag system
CN112979797B (zh) * 2021-04-28 2022-04-01 中国检验检疫科学研究院 一种抗赤羽病病毒单克隆抗体及其制备方法与应用
GB202215634D0 (en) * 2022-10-21 2022-12-07 Glaxosmithkline Biologicals Sa Polypeptide scaffold

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090317420A1 (en) * 2004-07-29 2009-12-24 Chiron Corporation Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
US20090104218A1 (en) * 2004-12-22 2009-04-23 J. Craig Venter Institute Group B Streptococcus
GB0502095D0 (en) * 2005-02-01 2005-03-09 Chiron Srl Conjugation of streptococcal capsular saccharides
GB0605757D0 (en) * 2006-03-22 2006-05-03 Chiron Srl Separation of conjugated and unconjugated components
EP2063911A2 (en) 2006-07-26 2009-06-03 Novartis Ag Immunogenic compositions for gram positive bacteria
GB0802503D0 (en) 2008-02-11 2008-03-19 Novartis Ag Hybrid polypeptide
CN102481349B (zh) * 2009-01-12 2014-10-15 诺华股份有限公司 抗革兰氏阳性细菌疫苗中的Cna_B结构域
GB201003333D0 (en) * 2010-02-26 2010-04-14 Novartis Ag Immunogenic proteins and compositions
GB201005625D0 (en) * 2010-04-01 2010-05-19 Novartis Ag Immunogenic proteins and compositions
GB201114923D0 (en) * 2011-08-30 2011-10-12 Novartis Ag Immunogenic proteins and compositions
CN104321335A (zh) * 2012-02-24 2015-01-28 诺华股份有限公司 菌毛蛋白质和组合物

Similar Documents

Publication Publication Date Title
JP2017523985A5 (enExample)
JP2013079285A5 (enExample)
JP2012501959A5 (enExample)
JP2016040284A5 (enExample)
JP2013504556A5 (enExample)
IL276210B2 (en) Mers-cov vaccine
JP2013503110A5 (enExample)
JP2015529678A5 (enExample)
RU2017144606A (ru) Иммуноцитокины на основе il-15 и il-15rа домена sushi
JP2012126742A5 (enExample)
HRP20191852T1 (hr) Polipeptidi
JP2016527286A5 (enExample)
JP2016512425A5 (enExample)
NZ601818A (en) Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of gastric cancer and other cancers
JP2016513638A5 (enExample)
FI2970398T3 (fi) Rsv f -prefuusioproteiineja ja niiden käyttö
JP2015501329A5 (enExample)
EP2582719A4 (en) Single chain insulin agonists exhibiting high activity at the insulin receptor
RU2017104529A (ru) Композиции neisseria meningitidis и способы их применения
JP2012522802A5 (enExample)
JP2015518818A5 (enExample)
JP2019506862A5 (enExample)
JP2015505309A5 (enExample)
JP2013520487A5 (enExample)
BR112015009280A2 (pt) preparações liofilizadas de melfalana flufenamida